U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751328) titled 'Feasibility Assessment of the Wellumio 'Axana' 0.1T Portable MRI Device' on May 24, 2024.
Brief Summary: To assess the safety and feasibility of the Wellumio 'Axana' device in the hospital setting with healthy controls and patients.
Study Start Date: July 01, 2024
Study Type: INTERVENTIONAL
Condition:
Stroke
Acute Stroke
Ischemic Stroke
Hemorrhagic Stroke
Intervention:
DIAGNOSTIC_TEST: Axana Scan and MRI
Patients will be booked in for a hospital MRI scan as per standard in-hospital processes. On the day of the MRI scan, patients will have two 'Axana' device scans (Scan 1 & 2). These scans must all happen on the same day and no...